Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Versteijne E, van Dam JL, Suker M, et al. Neoadjuvant chemoradiotherapy versus upfront Surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial. J Clin Oncol. 2022;40:1220–30.

    Article  CAS  Google Scholar 

  2. Ueno H, Ikeda M, Ueno M, et al. Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2016;77:595–603.

    Article  CAS  Google Scholar 

  3. Chiorean EG, Cheung WY, Giordano G, et al. Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review. Ther Adv Med Oncol. 2019;11:1758835919850367.

    Article  Google Scholar 

  4. Ikenaga N, Miyasaka Y, Ohtsuka T, et al. A prospective multicenter phase II trial of neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancer with arterial involvement. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12566-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    Naoki Ikenaga MD, PhD & Masafumi Nakamura MD, PhD

  2. Department of Surgery, Fukuoka University Chikushi Hospital, Chikushino, Japan

    Yoshihiro Miyasaka MD, PhD

  3. Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical Sciences, Kagoshima University, Kagoshima, Japan

    Takao Ohtsuka MD, PhD

Authors
  1. Naoki Ikenaga MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Miyasaka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takao Ohtsuka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masafumi Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masafumi Nakamura MD, PhD.

Ethics declarations

Disclosure

The authors report no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Naoki Ikenaga and Yoshihiro Miyasaka shares co-first authorship.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ikenaga, N., Miyasaka, Y., Ohtsuka, T. et al. ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement. Ann Surg Oncol 30, 203–204 (2023). https://doi.org/10.1245/s10434-022-12584-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12584-z

Search

Navigation